0001144204-11-014126.txt : 20110310 0001144204-11-014126.hdr.sgml : 20110310 20110310210132 ACCESSION NUMBER: 0001144204-11-014126 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110308 FILED AS OF DATE: 20110310 DATE AS OF CHANGE: 20110310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geehr Edward CENTRAL INDEX KEY: 0001475152 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 11680048 MAIL ADDRESS: STREET 1: C/O NEOSTEM, INC. STREET 2: 420 LEXINGTON AVENUE, SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeoStem, Inc. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-584-4171 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE DATE OF NAME CHANGE: 20030819 FORMER COMPANY: FORMER CONFORMED NAME: CORNICHE GROUP INC /DE DATE OF NAME CHANGE: 19951117 FORMER COMPANY: FORMER CONFORMED NAME: FIDELITY MEDICAL INC DATE OF NAME CHANGE: 19951025 4 1 v214200_ex.xml X0303 4 2011-03-08 0 0000320017 NeoStem, Inc. NBS 0001475152 Geehr Edward C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450 NEW YORK NY 10170 1 0 0 0 Stock Options (right to buy) 1.82 2011-03-08 4 A 0 115000 0 A 2014-03-07 Common Stock, par value $0.001 per share 115000 115000 I By Acute Care Partners On March 8, 2011, the effective date (the "Effective Date") of a consulting agreement (the "Consulting Agreement") between NeoStem, Inc. (the "Company") and Acute Care Partners, a California corporation (the "Consultant"), the Consultant was granted an option to purchase 115,000 shares of common stock, par value $0.001 per share, of the Company, pursuant and subject to the terms and conditions of the Company's 2009 Equity Compensation Plan. The Consultant is a wholly-owned corporate alter ego of the reporting person. Pursuant to the terms of the Consulting Agreement, the Consultant (through the reporting person) will provide consulting services to the Company. This option is scheduled to vest as to 28,750 shares on each of April 8, 2011, May 8, 2011, June 8, 2011 and July 8, 2011, provided that the Consultant (through the reporting person) continues to be providing consulting services to the Company on each of such dates. *Executed pursuant to a power of attorney filed herewith. Exhibit List: Exhibit 24.1 - Power of Attorney Edward C. Geehr, M.D., By: /s/ Catherine M. Vaczy, Esq., Attorney-in-Fact* 2011-03-10 EX-24.1 2 v214200_ex24-1.htm Unassociated Document
 
POWER OF ATTORNEY

Know all by these presents, that Edward C. Geehr, M.D. hereby constitutes and appoints each of Robin L. Smith, Catherine Vaczy, Esq. and Alan Wovsaniker, Esq., his true and lawful attorney-in-fact with respect to NeoStem, Inc. to:

 
1.
execute for an on behalf of the undersigned Schedules 13D and 13G, Form ID, and Forms 3, 4, and 5 in accordance with Sections 13 and 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

 
2.
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Schedules 13D or 13G, Form ID, and Forms 3, 4, or 5, and the timely filing of such forms with the United States Securities and Exchange Commission and any other authority; and

 
3.
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, including without limitation the execution and filing of a Form 4 with respect to a transaction which may be reported on a Form 5, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as he might or could do in person, with full power of substitution and resubstitution, hereby ratifying and confirming all that such attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause to be done in virtue of this Power of Attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Sections 13 and 16 of the Securities Exchange Act of 1934.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 9th day of March, 2011.
 
 
Edward C. Geehr, M.D.
   
   
 
/s/ Edward C. Geehr, M.D.